Killer T-cells (CD8 cells or cytotoxic T-lymphocytes) engineered to mount a rare and specific reaction to HIV-infected cells that was first seen in an experimental vaccine more than a decade ago were able to halve the number of cells containing intact viral DNA, the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali heard.
“We’re very excited about our findings,” Professor J. Victor Garcia of the University of Birmingham, Alabama told the conference.
Read the full news story at aidsmap.
All aidsmap reports from IAS 2025 can be accessed here.
Source : aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.